Research Groups

Health Physics, Radiation Biology, and Medical Physics

Quad Chart for Research Group

Group Members:

Recent Publications:

  1. J. K Wagner, J. A. Dillon, E. K. Blythe, and J. Ford, "Dose characterization of the RadSource 2400 X-ray irradiator for oyster pastuerization," Applied Radiation and Isotopes 67(2), 334-339 (2009).
  2. L. A. Braby, "A Solution to the Problem with Absorbed Dose," Nuclear Engineering and Technology 40(7), 533-538 (2008).
  3. A. S. Pasciak and J. R. Ford, "High-speed evaluation of track-structure Monte Carlo electron transport simulations," Physics in Medicine and Biology 53(19), 5539-5553 (2008).
  4. C. Guetersloh, L. Heilbronn, J. Miller, N. Elkhayari, A. Empl, M. LeBourgeois, B. W. Mayes, L. Pinsky, M. Christl, and E. Kuznetsov, "Shielding experiments with high-energy heavy ions for spaceflight applications," New Journal of Physics 10, 075007 (2008).
  5. J. H. Sampson, G. Akabani, G. E. Archer, M. S. Berger, R. E. Coleman, A. H. Friedman, H. S. Friedman, K. Greer, J. E. Herndon, II, S. Kunwar, R. E. McLendon, A. Paolino, N. A. Petry, J. M. Provenzale, D. A. Reardon, T. Z. Wong, M. R. Zalutsky, I. Pastan, and D. D. Bigner, "Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors," Neuro-Oncology 10(3), 320-9, 2008.
  6. J.W. Jung and W. D. Reece, "Dosimetric characterization of 142Pr glass seeds for brachytherapy," Applied Radiation and Isotopes 66, 441-449 (2008).
  7. C. Zeitlin, S. Guetersloh, L. Heilbronn, and J. Miller, "Fragmentation cross sections of medium-energy 35Cl, 40Ar, and 48Ti beams on elemental targets," Physical Review C 77, 034605 (2008).
  8. J. Vanamala, A. Glagolenko, P. Yang, R. J. Carroll, M. E. Murphy, R. A. Newman, J. R. Ford, L. A. Braby, R. S. Chapkin, N. D. Turner and J. R. Lupton, "Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARδ/PGE2 and elevation of PGE3," Carcinogenesis 29(4): 790-796 (2008).
  9. D. A. Reardon, M. R. Zalutsky, G. Akabani, R. E. Coleman, A. H. Friedman, J. E. Herndon, II, R. E. McLendon, C. N. Pegram, J. A. Quinn, J. N. Rich, J. J. Vredenburgh, A. Desjardins, S. Guruangan, S. Boulton, R. H. Raynor, J. M. Dowell, T. Z. Wong, X-G Zhao, H. S. Friedman, and D. D. Bigner , "A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost," Neuro-Oncology 10(2), 182-189, 2008.
  10. J. H. Sampson, G. Akabani, G. E. Archer, M. S. Berger, R. E. Coleman, A. H. Friedman, H. S. Friedman, K. Greer, J. E. Herndon, S. Kunwar, R. E. McLendon, A. Paolino, N. A. Petry, J. M. Provenzale, D. A. Reardon, T. Z. Wong, M. R. Zalutsky, I. Pastan, and D. D. Bigner, "Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors," Neuro-Oncology 10(3), 320-329, 2008.
  11. W.H. Hsu, L. A. Braby , and W. D. Reece, "Detection System Built from Commercial Integrated Circuits for Real-Time Measurement of Radiation Dose and Quality Using the Variance Method," Radiation Protection Dosimetry 128(1), 5-1 (2008).
  12. M. R. Zalutsky, D. A. Reardon, G. Akabani, R. E. Coleman, A. H. Friedman, H. S. Friedman, J. E. Herndon, II, R. E. McLendon, C. N. Pegram, J. M. Provenzale, J. A. Quinn, J. N. Rich, J. J. redenburgh, A. Desjardins, S. Guruangan, S. Sathornsumettee, J. H. Sampson, T. Z. Wong, X-G Zhao, and D. D. Bigner., "Clinical Experience with α-Emitting Astatine-211: Treatment of Recurrent Brain Tumor Patients with 211At-labeled Chimeric 81C6 Anti-Tenascin Monoclonal Antibody 81C6," Journal of Nuclear Medicine 49(1), 30-38, 2007.
  13. S. D. Pillai and L. A. Braby, "Electronic Pasteurization," Advances in Thermal and Non-Thermal Food Preservation . edited by G. Tawari and V. K. Juneja (Blackwell Publishing: 2008), pp.195-202
  14. C. La Tessa, L. Sihver, D. Mancusi, C. Zeitlin, J. Miller, S. Guetersloh and L. Heilbronn, "Weak and strong factorization properties in nucleus–nucleus collisions in the energy region 290–2100 MeV/nucleon," Nuclear Physics A 791(3-4), 451-472 (2007).
  15. C. La Tessa, L. Sihver, C. Zeitlin, J. Miller, S. Guetersloh, L. Heilbronn, D. Mancusi, Y. Iwata and T. Murakami, "Test of weak and strong factorization in nucleus–nucleus collisions at several hundred MeV/nucleon," Nuclear Physics A 791(3-4), 434-450 (2007).
  16. C. Zeitlin, S. Guetersloh, L. Heilbronn, and J. Miller, "Fragmentation cross sections of 290 and 400 MeV/nucleon 12C beams on elemental targets," Physical Review C 76(1), 014911 (2007).
  17. R. E. McLendon, G. Akabani, H. S. Friedman, D. A. Reardon, L. Cleveland, I. Cokgor, J. E. Herndon II, C. Wikstrand, S. T. Boulton, A. H. Friedman, D. D. Bigner, and M. R. Zalutsky., "Tumor Resection Cavity Administered Iodine-131-Labeled Antitenascin 81C6 Radioimmunotherapy in Patients with Malignant Glioma: Neuropathology Aspects," Nuclear Medicine and Biology 34(4), 405-13, 2007.
  18. C. Zeitlin,A. Fukumura, S.B. Guetersloh, L.H. Heilbronn, Y. Iwata, J. Miller, and T. Murakami, "Fragmentation cross sections of 28-Si at beam energies from 290A to 1200A MeV," Nuclear Physics A 784(1-4), 341–367 (2007).
  19. S. Vemulapalli, S. D. Metzler, G. Akabani, N. A. Petry, N. J. Niehaus, X. Liu, N. H. Patil, K. L. Greer, R. J. Jaszczak, R. E. Coleman, C. Dong, P.J. Goldschmidt-Clermont, and B. B. Chin, "Cell Therapy in Murine Atherosclerosis: In Vivo Imaging with High-Resolution Helical SPECT," Radiology 242(1), 198-207, 2007.